| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Principal Accounting Officer
1 company
Piskel Kyle is a Chief Financial Officer at ADPT. Recent filings cover 0 purchases and 13 sales. Those positions are worth an estimated $3.3M at current prices.
Our model assigns Piskel Kyle a below-average insider score of 40/100, based on 10 past trades. Over a 12-month horizon, 16.7% of those trades were profitable, with an average 12-month return of -56.6%.
Piskel Kyle's largest disclosed position is in ADPT as Chief Financial Officer, worth about $3.3M. The recent filings there lean toward selling, a net 209,838 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | ADPT Adaptive Biotechnologies Corporation | Chief Financial Officer | Sell | 3,115 | $13.04 | $40,619.60 | -1.2% | - | - | |
| Mar 11, 2026 | ADPT Adaptive Biotechnologies Corporation | Chief Financial Officer | Sell | 18,672 | $13.17 | $245,910.24 | -6.7% | +22.1% | - | |
| Jan 12, 2026 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 4,290 | $18.00 | $77,220.00 | -1.9% | -30.0% | - | |
| Nov 28, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 162,820 | $19.50 | $3,174,990.00 | -42.9% | -16.3% | - | |
| Nov 17, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sell | 238 | $14.05 | $3,343.90 | - | +15.2% | - | |
| May 16, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sell | 1,929 | $8.89 | $17,148.81 | -0.7% | +42.8% | +41.8% | |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sell | 10,320 | $6.98 | $72,072.21 | -3.7% | +23.8% | +98.3% | |
| Nov 18, 2024 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sell | 248 | $4.98 | $1,235.04 | -0.2% | +76.7% | +193.8% | |
| Mar 5, 2024 | ADPT Adaptive Biotechnologies Corp | Principal Accounting Officer | Sell | 7,727 | $3.43 | $26,503.61 | -5.9% | -12.4% | +112.4% | |
| Nov 16, 2023 | ADPT Adaptive Biotechnologies Corp | Principal Accounting Officer | Sell | 259 | $4.13 | $1,069.67 | -0.3% | -2.2% | +26.1% |